Therefore, even though the GABARAPL1 expression was significantly higher in AMD patients compared to that in CATA patients, the variability of gene expression from patients was high, likely due to individual difference and severity in each patient. The gene discussed is GABARAPL1; the disease is age-related macular degeneration.